Guizhou Salvage Pharmaceutical Co Ltd
SSE:600227
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (13.4), the stock would be worth ¥2.54 (31% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 19.3 | ¥3.68 |
0%
|
| 3-Year Average | 13.4 | ¥2.54 |
-31%
|
| 5-Year Average | 20.1 | ¥3.84 |
+4%
|
| Industry Average | 26.3 | ¥5 |
+36%
|
| Country Average | 20.8 | ¥3.96 |
+8%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Guizhou Salvage Pharmaceutical Co Ltd
SSE:600227
|
6.2B CNY | 19.3 | -30.4 | |
| US |
|
Corteva Inc
NYSE:CTVA
|
53.6B USD | 14.7 | 48.7 | |
| CA |
|
Nutrien Ltd
TSX:NTR
|
47.7B CAD | 11 | 14.9 | |
| CN |
|
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
|
188.9B CNY | 16.5 | 22.7 | |
| CL |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
25.4B USD | 22.6 | 43.2 | |
| CN |
|
Zangge Mining Co Ltd
SZSE:000408
|
137.1B CNY | 70.4 | 29.3 | |
| US |
|
CF Industries Holdings Inc
NYSE:CF
|
18.6B USD | 7.2 | 12.8 | |
| NO |
|
Yara International ASA
OSE:YAR
|
136.8B NOK | 8.1 | 10.5 | |
| SA |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
53.8B SAR | 7.7 | 12.4 | |
| RU |
|
PhosAgro PAO
MOEX:PHOR
|
912.2B RUB | 9 | 7.9 | |
| CN |
|
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
|
77.1B CNY | 20 | 23.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 11.5 |
| Median | 20.8 |
| 70th Percentile | 39.2 |
| Max | 266 666.7 |
Other Multiples
Guizhou Salvage Pharmaceutical Co Ltd
Glance View
Guizhou Salvage Pharmaceutical Co., Ltd. engages in the operation of chemical fertilizer and pharmaceutical business. The company is headquartered in Guiyang, Guizhou and currently employs 1,227 full-time employees. The company went IPO on 2000-02-21. The firm is engaged in the production and sales of urea and methyl alcohol. The firm is also engaged in the production and sales of drugs, medical devices and health products. Its drugs are applied in the treatment of diabetes and others. The firm also engages in the distribution of pharmaceuticals. The firm mainly operates its businesses in Guizhou, Sichuan, Chongqing, Guangxi, Gunagdong, Hunan and other regions.
